SCHEMBL3923717

SCHEMBL3923717

Fc1ccc(CC2(COCCc3cc(Cl)cc4cn(C5CC5)nc34)CCNCC2)cc1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 1/20 0.32
SLC6A4 P31645 1/20 0.32
KCNH2 Q12809 1/20 0.32
TLR8 Q9NR97 3/20 0.31
OPRL1 P41146 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3925993 0.84 TACR1 (0.33) TACR1SLC6A4KCNH2
SCHEMBL3923714 0.77 TACR1 (0.46) TACR1SLC6A4KCNH2
SCHEMBL3935770 0.77
SCHEMBL3934563 0.76 TACR1 (0.33) TACR1SLC6A4KCNH2
SCHEMBL3926137 0.76 TACR1 (0.30) TACR1SLC6A4KCNH2
SCHEMBL3928326 0.76 TACR1 (0.39) TACR1SLC6A4KCNH2
SCHEMBL3923318 0.75 TACR1 (0.35) TACR1SLC6A4KCNH2
SCHEMBL3924647 0.71 MEN1 (0.33) TACR1SLC6A4KCNH2
SCHEMBL3927950 0.71 HTR1A (0.31) SLC6A4
SCHEMBL3930993 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009009411-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-15 WO claimed
WO-2009009411-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-15 WO disclosed